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Gout is an inﬂammatory arthritis characterized by the deposition of monosodium urate
crystals in the synovial membrane, articular cartilage and periarticular tissues leading to
inﬂammation. Men are more commonly affected, mainly after the 5th decade of life. Its
incidence has been growing with the population aging.
In the majority of the cases, the diagnosis is made by clinical criteria and synovial ﬂuid
analysis, in search for monosodium urate crystals. Nonetheless, gout may sometimes have
atypical presentations, complicating the diagnosis. In these situations, imaging methods
have a fundamental role, aiding in the diagnostic conﬁrmation or excluding other possible
differential diagnosis.
Conventional radiographs are still the most commonly used method in gout patients’
evaluation; nevertheless, this is not a sensitive method, since it detect only late alterations.
In  the last years, there have been several advances in imaging methods for gout patients.
Ultrasound has shown a great accuracy in the diagnosis of gout, identifying monosodium
urate deposits in the synovial membrane and articular cartilage, in detecting and character-
izing tophi and in identifying tophaceous tendinopathy and enthesopathy. Ultrasound has
also  been able to show crystal deposition in patients with articular pain in the absence of a
classical gout crisis.
Computed tomography is an excellent method for detecting bone erosions, being use-ful  in spine involvement. Dual-energy CT is a new method able to provide information
about the chemical composition of tissues, with high accuracy in the identiﬁcation of
eposits, even in the early stages of the disease and in cases of difﬁcultmonosodium urate dPlease cite this article in press as: De Avila Fernandes E, et al. Relevant aspects of imaging in the diagnosis and management of gout. Rev Bras
Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.05.001
characterization.
 Study developed at Hospital do Servidor Público Estadual “Francisco Morato de Oliveira” (HSPE-FMO), São Paulo, SP, Brazil.
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Magnetic resonance imaging is useful in the evaluation of deep tissues not accessible by
ultrasound.
Besides the diagnosis, with the emergence of new drugs that aim to reduce tophaceous
burden, imaging methods have become useful tools in monitoring the treatment of patients
with gout.
© 2016 Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Aspectos  relevantes  do  diagnóstico  e  seguimento  por  imagem  na  gota
Palavras-chave:
Gota
Ultrassonograﬁa
Ressonância magnética
Tomograﬁa computadorizada de
dupla energia
r  e  s  u  m  o
A gota é uma artrite caracterizada pela deposic¸ão de cristais de monourato sódico na mem-
brana sinovial, na cartilagem articular e nos tecidos periarticulares que leva a um processo
inﬂamatório.
Na  maioria dos casos o diagnóstico é estabelecido por critérios clínicos e pela análise
do  líquido sinovial, em busca dos cristais de MSU. Porém, a gota pode se manifestar de
maneiras atípicas e diﬁcultar o diagnóstico. Nessas situac¸ões, os exames de imagem têm
papel fundamental, auxiliam na conﬁrmac¸ão diagnóstica ou ainda excluem outros diagnós-
ticos  diferenciais.
A radiograﬁa convencional ainda é o método mais usado no acompanhamento desses
pacientes, porém é um exame pouco sensível, por detectar somente alterac¸ões tardias.
Nos  últimos anos, surgiram avanc¸os nos métodos de imagem em relac¸ão à gota. O ultra-
ssom se mostra um exame de grande acurácia no diagnóstico de gota, identiﬁca depósitos
de  MSU na cartilagem articular e nos tecidos periarticulares e detecta e caracteriza tofos,
tendinopatias e entesopatias por tofos.
A  tomograﬁa computadorizada é um ótimo exame para a detecc¸ão de erosões ósseas
e  avaliac¸ão do acometimento na coluna. A tomograﬁa computadorizada de dupla-energia,
um método novo, fornece informac¸ões sobre a composic¸ão química dos tecidos, permite a
identiﬁcac¸ão  dos depósitos de MSU com elevada acurácia.
A ressonância magnética pode ser útil na avalic¸ão dos tecidos profundos, não acessíveis
ao  ultrassom.
Além do diagnóstico, com o surgimento de drogas que visam reduzir a carga tofácea,
os  exames de imagem se tornam uma ferramenta útil no acompanhamento do tratamento
dos  pacientes com gota.
© 2016 Publicado por Elsevier Editora Ltda. Este e´ um artigo Open Access sob uma
c¸a  Clicen
Introduction
Gout is an inﬂammatory arthritis, characterized by periods of
hyperuricemia and deposition of mono sodium urate (MSU)
in the articular cartilage, subchondral bone, synovium, cap-
sule, periarticular tissues and in lower temperature areas such
as the superﬁcial tissues of the extremities, leading to an
inﬂammatory reaction.1,2 Genetic and dietary factors have
been implicated in increasing the level of MSU.2
Gout occurs in approximately 0.2–0.35 per 100 inhabitants
in the general population. The incidence is higher at the end
of the third/beginning of the fourth decade of life, predom-
inantly in males and in about 5% of women, usually after
menopause.2,3
Usually, the diagnosis is established by clinical and labo-
ratory workup, and the reference method is the analysis ofPlease cite this article in press as: De Avila Fernandes E, et al. Relevant as
Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.05.001
synovial ﬂuid; however, this is an invasive technique. Thus,
the therapy can be started based on the diagnostic criteria of
the American College of Rheumatology (ACR).4C BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
The importance of an accurate diagnosis and treatment of
gout should not be underestimated, because these patients
will depend on the therapy throughout their lives, in order
to diminish those morbidities associated with hyperuricemia.
Due to the multiple differential diagnoses, and also consider-
ing the atypical presentations of gout, imaging studies may be
useful in various stages of this disease.5
In the last decade, we  have witnessed important advances
in imaging techniques, assisting in the noninvasive diagnosis
and follow-up of patients being treated for gout. To the best
of our knowledge, no recent review of the imaging aspects for
gout was published in Brazilian literature. To the best of our
knowledge, there has not been any recently published review
of imaging aspects for gout in Brazilian literature. This review
aims to summarize recent advances in the literature related to
imaging studies, disclosing the relevant aspects to physicianspects of imaging in the diagnosis and management of gout. Rev Bras
of all specialties with respect to the diagnosis and follow-up
of gout patients by imaging methods, in view of the increase
and the high prevalence of this disease.
ARTICLE IN PRESSRBRE-298; No. of Pages 9
 . 2 0 1
M
A
a
“
l
r
w
p
T
t
e
D
F
h
a
o
t
g
s
i
o
w
o
t
i
l
j
i
t
h
u
i
i
o
t
p
t
b
a
c
t
c
e
t
c
o
l
i
ar  e v b r a s r e u m a t o l
ethods
 search of major databases (Medline, Lilacs, Cochrane Library
nd PubMed) was conducted with the use of the terms “gout,”
arthritis,” “tophaceous gout” and “urate”. Our search was
imited to original articles published in the last 5 years, but
eview articles and case reports of signiﬁcant clinical relevance
ere included in the survey.
More  than 700 articles and abstracts published on the
roposed topic in this review were identiﬁed in the search.
he selection was based on clinical importance; articles
hat showed no relationship with diagnostic imaging were
xcluded. At the end, 39 articles remained.
iscussion
our distinct clinical phases are recognized: asymptomatic
yperuricaemia, acute monophasic gout, recurrent acute
ttacks with intercritical periods and chronic gout which is
ften tophaceous1,2 (a sequence of such events is not manda-
ory and asymptomatic patients do not receive a diagnosis of
out). In each of these phases, it is possible to use imaging
tudies.
The typical clinical picture of cases of acute gouty arthritis
ncludes a painful acute monoarthritis of the ﬁrst metatarsal
r knee, with local inﬂammation and swelling, in association
ith elevated levels of uric acid.
Hyperuricemia is one of the clinical criteria for a diagnosis
f gout, but although this is the predominant risk factor for
his disease, elevated serum uric acid levels not always result
n deposition of crystals.6 Serum urate levels >6.8 mg/dl can
ead to precipitation and deposition of urate crystals in the
oints and soft tissues, but acute gout crisis can occur even
n patients with normal serum urate levels; in these cases
he clinical diagnosis is more  difﬁcult, and the doctor can get
elp through imaging methods. Imaging studies can also be
sed in atypical presentations, for example, in cases involv-
ng unusual age groups or locations, with prolonged and less
ntense symptoms at the time of presentation.5,6
The intercritical period is that following an acute episode
f a painful gout crisis, in which the patient remains asymp-
omatic. Advances in imaging techniques showed that, in
atients in the intercritical period, it is possible to detect
ophaceous deposits in up to 50% of joints that have already
een affected by acute episodes.5 It has also been shown that
symptomatic patients had tophaceous deposits in the spinal
olumn, detected by computed tomography (CT).7
Knowing that in many  cases patients, even when asymp-
omatic, may have already tophaceous deposits not detected
linically, it is worth questioning whether it is important to
valuate early joint, bone and tendon damage – or even the
ophaceous load – through imaging exams during the inter-
ritical phase. At this stage, the imaging evaluation, as far as
ur knowledge goes, is not yet a recommended practice in thePlease cite this article in press as: De Avila Fernandes E, et al. Relevant asp
Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.05.001
iterature.
A few years must elapse so that the tophus becomes clin-
cally evident after the ﬁrst attack; rarely these formations
re identiﬁed during this ﬁrst episode.1 Chronic tophaceous 6;x  x x(x x):xxx–xxx 3
gout is characterized clinically by the presence of tophi, which
are formed secondarily to the accumulation of uric acid, pro-
tein matrix, inﬂammatory cells and foreign body giant cells in
the tendons, ligaments, cartilages, bursae, subcutaneous cel-
lular tissue and in periarticular regions.5 The tophi are more
common on the extensor surfaces of the hands, elbows, feet,
knees, auricular appendages and the tip of the nose.
Although generally chronic tophaceous gout has a straight-
forward clinical diagnosis, in some cases the diagnosis can
be challenging, when the problem is associated with unusual
symptoms or with an atypical disease. Atypical clinical mani-
festations are seen more  frequently in certain segments of the
population, including the elderly, patients who  have under-
gone organ transplants, and cancer patients.6
The tophi nodules can also not be typical, and the physi-
cian should take into account some differential diagnosis
as ganglion, cysts, bursitis, hematoma, amyloidosis, throm-
bophlebitis, sarcoidosis, psoriatic arthritis, pyrophosphate
deposit arthritis, neoplasms, tenosynovitis, rheumatoid nod-
ules, osteoarthritis and infection.8,9
At this stage, the imaging studies may be valid for the
assessment of disease severity, the extent of MSU  deposition,
and the presence of chronic inﬂammation. Moreover, images
may constitute a useful tool for monitoring the response to a
reduction of uric acid therapy.10
Monitoring  and  response  to  treatment
Several methods have been developed and evaluated by the
Outcomes Measures in Rheumatology (OMERACT) in order to
quantify tophi in patients with chronic tophaceous gout, from
the simplest methods, for instance, by physical examination,
to more  sophisticated means with the use of imaging tests.
In patients with a chronic tophaceous gout, quantiﬁcation of
tophi and documentation of regression with treatment are
important measures of monitoring, in order to prevent joint
destruction. Patients with elevated levels of uric acid do not
necessarily exhibit higher masses of tophi, compared with
patients with low levels of uric acid.11,12
Among the methods using physical examination, the main
ones are number of tophi counting, physical measurement
with a measuring tape, the use of a speciﬁc instrument called
Vernier caliper, and digital photography.13
Ultrasound is a good tool for the evaluation of response to
treatment, thanks to its availability and also because it has
good sensitivity. The use of computed tomography and mag-
netic resonance imaging, although less available techniques,
results in some advantages, such as data storage possibility
for later reading and visualization of intra-articular tophi, in
the absence of subcutaneous tophi.14–16
Dual-energy CT (DECT) is emerging as a good tool because
with its use the physician can demonstrate MSU deposits even
in asymptomatic patients. Although the ability of this tech-
nique in terms of quantifying tophi is a potentially usefulects of imaging in the diagnosis and management of gout. Rev Bras
feature to evaluate small changes in tophus load and although
the technique plays a role in monitoring the response to treat-
ment, its cost and the radiation exposure (albeit low)  mean
that the main role of DECT in monitoring treatment is limited
ARTICLE IN PRESSRBRE-298; No. of Pages 9
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to clinical trials of new therapeutic agents, with little use in
clinical practice.16
Image  methods
The imaging methods used for the evaluation of gout are plain
radiography (X-ray), ultrasound (US), DECT, CT and magnetic
resonance imaging (MRI).
Plain  radiography
Bloch et al.2 classiﬁed the radiological ﬁndings in early, inter-
mediate and late changes. Radiographic changes are more
frequent in the feet, especially in the ﬁrst metatarsopha-Please cite this article in press as: De Avila Fernandes E, et al. Relevant as
Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.05.001
langeal joint.2,10 In the initial presentation of gout, there is
no speciﬁc radiographic signs – only an increased soft tis-
sue volume and density. With X-rays, one cannot assess early
changes of the soft tissues such as effusion, initial erosion,
A
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Fig. 1 – (A) Anteroposterior radiography of feet of a patient with 
adjacent to the ﬁrst metatarsophalangeal (MTP) joint (arrow). On
ﬁrst metatarsal. (B) Detail of the previous image showing the hea
marked with an asterisk (*) with raised edges, and Martel’s sign 
the foot at the level of the ﬁrst MTP  joint, showing the cortical bo
joint space of the hallux, the cartilage of the head of the ﬁrst me
coating cartilage (small arrow), characterizing the double contou
surface (arrow) of the head of the ﬁrst metatarsal, articular cartil
characterizing the double contour sign. P, proximal; D, distal; TS
extensor hallucis tendon. 1 6;x  x x(x x):xxx–xxx
synovial hypertrophy, hypervascularization, or small tophi.
On the other hand, with MRI – which shows these changes
– is not always that the physician can establish an accu-
rate differentiation between gout and some of its differential
diagnosis.
X-ray is a fast method, and generally it is used in the ﬁrst
investigation of gout. X-ray has low sensitivity for diagnosis,
and there may be a gap from 6 to 12 years for the ﬁnding
of radiological evidence.2 In 2008, Rettenbacher et al. found
a sensitivity of 31–55% and a speciﬁcity of 93% for X-ray in
the diagnosis of gout.17 In cases of chronic tophaceous gout,
radiographic signs include visualizing tophi as soft tissue or
intraosseous masses, whether or not containing calciﬁcations;
and the presence of a non-demineralizing arthropathy accom-
panied by erosions presenting margins which may be scleroticpects of imaging in the diagnosis and management of gout. Rev Bras
or protruding. The Martel’s sign (Fig. 1) consists in the presence
of a protruding, salient bone edge separated from a tophus
and leaning on it.18,19 In X-ray, generally the joint space is
preserved until the disease is advanced.10
TE
CAB
∗
∗
gout showing increased volume and density of soft tissues
e can also observe bone erosion in distal metaphysis of the
d of the ﬁrst left metatarsal, evidencing bone erosion
(arrow). (C) Ultrasound image with longitudinal section of
ne of the head of ﬁrst metatarsal (large arrow), the MTP
tatarsal (*) and a thin hyperechoic layer overlying the
r sign. (D) Detail of the previous image showing the bone
age (*) and the thin hyperechoic layer (small arrow),
, subcutaneous tissue; ESP, phalangeal space of hallux; TE,
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According to Bloch,16 X-ray is a method with little use in
he evaluation of treatment, primarily by its low sensitivity in
etecting the disease in its early stages, but also, because it
s based on the presence of late ﬁndings, such as increases in
oft tissue, cortical erosions, and lytic injuries.
ltrasound
he high resolution of US allows us to identify the various
orms of presentation of gout and its relationship with the
ifferent tissues, helping in an early and noninvasive diag-
osis, therapeutic decision and management of treatment. In
ddition, US is a very useful method of assessing the extent
nd measurement of lesions and in the involvement of adja-
ent structures, with low interobserver variability; besides, US
ulﬁll the necessary characteristics for the evaluation of ther-
peutic response. As for histopathologic conﬁrmation of gout,
S is also useful in guiding punctures or biopsies.19,20
US detects early changes in the soft tissues in cases of gout
nd can be used especially when the clinical, laboratory and
adiographic studies are negative or inconclusive. There are
everal other advantages with the use of this technology: it is
oninvasive, easy to repeat the exam, ability to differentiate
etween solid versus cystic lesions, low cost, patient contact,
bsence of ionizing radiation, the possibility of acquisition of
ultiplanar and high-resolution images, dynamic assessment
f the joint and tendons, and effective guidance in invasive
rocedures.9,19,21 Some studies comparing the sensitivity and
peciﬁcity of US versus X-ray showed that US is more  sensi-
ive and earlier that X-ray, because the sonographic changes
re present at earlier stages, in comparison to typical X-ray
ignals.17,19,22
Sonographic aspects which are characteristic for the diag-
osis of gout are the “double contour signal” (Fig. 1), which is
haracterized by an irregular linear hyperechoic layer on the
uperﬁcial margin of the anechoic hyaline cartilage and par-
llel to the bone cortex, without a posterior acoustic shade.
n a Thiele’s 2007 study,19 this signal was observed in 92% ofPlease cite this article in press as: De Avila Fernandes E, et al. Relevant asp
Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.05.001
atients with biopsy-conﬁrmed gout, and none of the controls.
But patients with asymptomatic hyperuricemia may show
he sign of the double contour, observed in the study of Pineda
t al. in 25% of the metacarpophalangeal joints.20 Moreover,
p
cb 5
D
A
mtt
ig. 2 – Fifth metatarsophalangeal. (A and B) Sonographic image
yperechoic, nodule located in the soft tissues adjacent to the m
ndeﬁned by the attenuation of the acoustic beam. P, proximal; D 6;x  x x(x x):xxx–xxx 5
with the reduction of uric acid levels, this signal tends to dis-
appear in up to 7 months.22
In 2008, Rettenbacher et al.17 found sensitivity and speci-
ﬁcity of respectively 80% and 75% for the bright hyperechoic
foci in synovial tissue (microtophi) and 79% and 95% for
hyperechoic areas for the diagnosis of gout. Considering the
presence of either of the two ﬁndings, ultrasound had a sensi-
tivity of 96% and speciﬁcity of 73%. The speciﬁcity is not higher
because punctate hyperechoic foci, which may represent
microtophi, can also be observed in cases of osteoarthritis,
rheumatoid arthritis and chondrocalcinosis.23
When the bright hyperechoic foci are seen in combination
with the double contour signal, the speciﬁcity reaches 100%,
but with a considerable reduction of sensitivity.24
In cases where the doctor depends on an imaging study,
the knowledge of the sonographic features of tophus is impor-
tant so that one can differentiate between tophaceous nodules
and nodules from other etiologies (Fig. 2). US uses criteria that
help to differentiate between nodules caused by cancer and
inﬂammatory and infectious processes. In 2003, Nalbant,10
comparing tophi nodules and rheumatoid nodules, showed
that 80% of tophi were heterogeneous and of these, 75%
were hyperechoic; furthermore, this author observed only 15%
of heterogeneity and hyperechogenicity in rheumatoid nod-
ules. The rheumatoid nodule is more  homogeneous and can
present a well-deﬁned, hypoechoic central area due to the
occurrence of necrosis. Since rheumatoid nodules rarely cal-
cify, this feature also helps to differentiate these formations
from tophi, which can calcify.
The presence of calciﬁcations with posterior acoustic shad-
owing and irregularities of the cortical bone underlying to
nodules also favor a diagnosis of tophi. There is no correlation
between disease duration and the presence of calciﬁcations
in tophi. The tophi are hyperechoic in 96.3% and hypoe-
choic in 3.7% of cases.12 The hyperechogenicity noted in tophi
represents deposits of urate or calciﬁcations. Small hyper-
echoic particles, or bright foci, measure less than 1 mm in
size and represent synovial microtophi.17 An agglomerate of
microtophi form hyperechoic the tophus; therefore, hyper-ects of imaging in the diagnosis and management of gout. Rev Bras
echogenicity and heterogeneity are strong indicators of a
tophus.
The hypoechoic halo in tophus periphery is a hypoechoic
band observed partially or completely around the tophus and
B
tr
. Longitudinal (A) and cross (B) sections of an amorphous,
etatarsocuboid joint. The structures deep to the node are
, distal.
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may correspond to inﬂammation, ﬁbrosis or edema. This halo
is observed in large parts of tophi and can be a marker for
tophaceous nodule.12
The sonographic features of tophi in relation to the tendons
may help to explain the clinical pictures showing movement
restrictions of patients with chronic tophaceous gout; further-
more, their knowledge can avoid invasive procedures, such as
biopsies. A ﬁve-type classiﬁcation of the relationship between
tophi and the tendon in patients with chronic tophaceous gout
was proposed,25 based on their location: tendon surrounded
by tophi, no relationship between tophus and tendon, tophi in
the tendon insertion site (enthesopathy), extrinsic compres-
sion, and tophi within the tendon.
Enthesopathy secondary to tophi is a recent ﬁnding in the
literature; and although it has been described in only 7% of
cases of chronic tophaceous gout, this possibility should be
considered in the differential diagnosis, depending on the
clinical context. The differential diagnosis of enthesopathy
is broad and includes calcium pyrophosphate deposition dis-
ease, degenerative disease, acromegaly, hyperparathyroidism,
hypoparathyroidism, and rheumatoid arthritis, among others.
The intratendinous tophus tends to evolve to the rupture of
the tendon26 and an early sonographic diagnosis may assist
the physician in establishing an effective treatment while
avoiding damage that, if not treated medically, may evolve
into the need for surgical treatment. Inside the tendon, the
tophi may have microdeposits demonstrated by bright, ovoid
and hyperechoic spots. Chronic intratendinous tophi can bePlease cite this article in press as: De Avila Fernandes E, et al. Relevant as
Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.05.001
evidenced as hyperechoic bands, occasionally accompanied
by a posterior acoustic shadow.27
US allows the visualization of the changes in the inﬂamma-
tory process of gout. The evaluation of gout by color Doppler
T
A
B
T 
Fig. 3 – (A) sonographic image in the longitudinal plane in the ﬁr
gouty crisis. One can observe the presence of bone erosions (//) a
shows increased vascularity in tophi. Cortical bone (arrows). 1 6;x  x x(x x):xxx–xxx
US demonstrates increased ﬂow in the acute phase of the
podagra crisis, which normalizes partially in 7 days. Gener-
ally, color shows no ﬂow when the patient is out of the gout
crisis,10 but in the author’s practice it has been observed that
painful periarticular areas in patients with a known diagnosis
of gout can exhibit hyperechoic tophi and ﬂow with Doppler,
even without the classic signs of crisis, which explains the
atypical clinical pictures of gouty arthralgia. However, these
ﬁndings depend on further studies to justify their use (Fig. 3).
Bone erosions are deﬁned as cortical discontinuities
observed in two perpendicular planes. This is a late ﬁnding
and has low sensitivity in diagnosing tophaceous gout; how-
ever, these erosions are slightly better detected by US versus
X-ray (24% versus 20% of cases).17
The dimensions of the gouty tophus assume importance
in assessing the response to treatment; therefore, in order
to acquire practical utility, the method used for this purpose
must show a good reproducibility. Perez-Ruiz et al. showed
that US is able to detect all periarticular tophi identiﬁed by
MRI.10,28 After the publication of these studies, OMERACT has
considered US as a possibly useful method in measuring gouty
tophi; but new clinical trials must be conducted for validation
of this method.
Computed  tomography  (CT)
CT allows the visualization of tophi in both the subcutaneouspects of imaging in the diagnosis and management of gout. Rev Bras
tissue and in intra-articular areas. This method also helps to
identify bone erosion, being more  sensitive than X-ray and MRI
for this purpose. A systematic analysis showed that CT detects
the presence of intraosseous tophi in 81% of joints presenting
T
Erosoes
T
st metacarpal. Patient with pain without evidence of a
nd tophi (T) adjacent to the erosions. (B) The color Doppler
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rosion and in 100% of cases when the erosion is greater than
.5 mm.29
CT can also reveal MSU  deposits inside tophi, thanks to its
ttenuation close to 160 UH, compared to calcium deposits,
hich have higher attenuation, around 450 UH.30 Thus, CT
an assist in the differentiation with respect to other types of
oft tissue nodules. CT can be used as a complementary imag-
ng method in the evaluation of damage to deeper structures,
hen methods that do not use ionizing radiation could not
onﬁrm its presence. In cases of involvement of deep struc-
ures such as the spine, possibly CT can complement an MRI
tudy, by demonstrating masses of tophi with compression of
erve structures.
While it may be useful, CT is not recommended as a method
f choice in the evaluation of gout on surface structures due
o the ionizing radiation exposure.
ual-energy  computed  tomography  (DECT)
ECT is a method that provides information about the chem-
cal composition of tissues and allows their differentiation.
hrough this technique, it is possible to distinguish MSU  crys-
als from gout, bone or dystrophic calciﬁcation.6 In some
tudies examining the deposition of articular and periartic-
lar crystals using DECT, high sensitivity and speciﬁcity were
bserved. Variations on the data obtained could be due to the
ifferent joints evaluated, protocols used and different stages
f this disease.30–34
In the early stages of the disease when the MSU deposits
re microscopic and with an intra-articular location, not being
acroscopic tophi, DECT may not be able to detect them, since
his technique has a size threshold, usually of 2 mm – the
echnique is not able to distinguish deposits with dimensions
elow this limit.35 In addition to the limitations related to the
ize of deposits, DECT is susceptible to some artifacts, mainly
elated to metallic devices, calluses, nails and thickened skinPlease cite this article in press as: De Avila Fernandes E, et al. Relevant asp
Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.05.001
reas such as that in the heel.
Most studies did not explore the diagnostic accuracy
f DECT in the ﬁrst presentation of gouty arthritis. Based
n limited published data, in the ﬁrst episode of gouty
ig. 4 – MRI  images of the foot on the long (A) and short (B) axis,
etatarsophalangeal joint, in association with a pattern of medu
fth metatarsal (*), as well as a densiﬁcation of the adjacent fat p 6;x  x x(x x):xxx–xxx 7
arthritis, the diagnostic sensitivity is low, around 50%.36 In
a study of 21 patients comparing the diagnostic accuracy of
US versus DECT in cases with suspected gout, the authors
observed similar sensitivity in these two methods, with false-
negative results in DECT accurately detected with US.16
DECT may be used to assess gout, regardless of serum
uric acid levels, and can conﬁrm the disease in patients with
normal serum uric acid levels, or exclude it in patients with
hyperuricemia. The general burden or uric acid deposition
volume may be calculated on individual lesions, joints, or in
the entirely digitalized area. A possible disadvantage of DECT
could be the patient’s exposure to ionizing radiation, but the
dose is less than the natural annual dose received and much
lower than the potentially malignancy-inducing values.22 Due
to the cost and to the radiation exposure (albeit low), its main
role, monitoring the treatment, is limited to clinical trials of
new therapeutic agents, more  than in clinical practice.16
Magnetic  resonance
MRI  is not routinely used to evaluate tophaceous gout. This
technique can be used to recognize the cause of motion lim-
itations, motor or painful disorders secondary to changes in
deep structures or that are coated with bone; in such event,
the access through US is not suitable (Fig. 4).
MRI is also useful for assessing the differential diagnosis
of soft tissue masses on the extremities.31 In MRI studies,
usually the tophus presents itself as a juxta-articular mass
of soft tissue, causing periarticular erosions and synovial
thickening. Using this technique, the appearance of tophi is
variable. In T2-weighted sequence, there is a variation of a low-
to-high signal, with a homogeneous or non-homogeneous
pattern, depending on the degree of hydration and calci-
ﬁcation. The most common appearance in a T2-weighted
sequence is a low-to-intermediate, heterogeneous signal. In
a T1-weighted sequence, its appearance is more  consis-ects of imaging in the diagnosis and management of gout. Rev Bras
tent, generally exhibiting a low-to intermediate signal. The
enhancement pattern is also variable. Another feature is the
enhancement surrounding the tophus; probably this is related
to the adjacent granulation tissue (Fig. 5).37
 showing joint effusion (arrow) in the ﬁfth
llary bone edema in the head and distal metaphysis of the
lanes (arrowhead).
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Fig. 5 – Sagittal MRI  images: T1-weighted (A), T2-weighted (B), axial T2-weighted (C) and sagittal after contrast (D) images of
the foot showing heterogeneous material with isosignal on T1, heterogeneous hyperintense signal on T2, with
etic c
rheterogeneous enhancement after IV injection of paramagn
MRI  also provides information on the morphology of tophi,
which can range from small nodular masses deposited in
poorly deﬁned anatomical planes, even with a permeative
aspect.38
Perez-Ruiz et al. evaluated the measurement of tophi in
a comparison between US and MRI, including the change in
tophus size and its association with serum concentrations of
urate in the course of 12 months. In this study, the diameters
evaluated in MRI  were larger than those obtained with the use
of US, and this may be related to better MRI  imaging for the soft
tissue component of the tophus, which can contain regions of
inﬂammation and hypervascularity.10
Recent studies have shown that MRI  can detect early artic-
ular erosions that are not radiographically apparent.39 Faced
with an acute gouty arthritis, it is common the occurrence
of periarticular edema, synovitis, and joint effusion, as well as
the presence of a high signal in bone marrow and periarticular
soft tissues; but these changes can be seen in any inﬂamma-
tory arthropathy, thus being unspeciﬁc ﬁndings. MRI is not a
relevant technique to help in the establishment of the initialPlease cite this article in press as: De Avila Fernandes E, et al. Relevant as
Reumatol. 2016. http://dx.doi.org/10.1016/j.rbre.2016.05.001
diagnosis of gout. For these reasons, MRI  should not be rou-
tinely used for the diagnosis of gout in its early stages, both in
cases of typical clinical presentation, as in atypical cases.ontrast in the dorsal aspect of the foot (arrows).
Conclusion
Imaging methods can be useful to aid in the diagnosis and
monitoring of treatment of patients with gout and, in partic-
ular, the use of ultrasound, which is an available, noninvasive
tool which provides good results. The potential of ultrasound
diagnosis has increased the interest among physicians. This
is a readily available, non-invasive tool that can be used for
the investigation of this disease.
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